TYMPANOSCLEROSIS — 50 MARKS (RGUHS)

1. DEFINITION

• When limited to the tympanic membrane → Myringosclerosis
• When involving the middle ear mucosa and ossicles → Tympanosclerosis (proper)

"Tympanosclerosis is thought to be a complication of otitis media in which acellular hyaline and calcified deposits accumulate within the tympanic membrane and the submucosa of the middle ear." — Cummings Otolaryngology, 7th Ed.

2. HISTORICAL BACKGROUND

• The term "tympanosclerosis" was introduced by von Troltsch (1873), who described chalky-white deposits on the tympanic membrane.
• Zöllner and Birken (1956) described the clinical and surgical significance of middle ear involvement.
• Detailed histopathological description was provided by Hussl and Lim (1984) — "Recent Advances in Otitis Media with Effusion" — who elaborated on the two-pathway mechanism of plaque formation.
• Kinney (1978) reported 20% incidence in patients undergoing surgery for chronic otitis media.

3. INCIDENCE AND EPIDEMIOLOGY

4. AETIOLOGY AND PREDISPOSING FACTORS

Primary Causes:

1. Chronic otitis media (CSOM) — most common
2. Recurrent acute otitis media (AOM)
3. Otitis media with effusion (OME) + grommet insertion
4. Eustachian tube dysfunction — deformation alone (without infection) shown to cause tympanosclerosis in rats (Wielinga et al.)
5. Trauma — iatrogenic (myringotomy, paracentesis), temporal bone fracture

Microbial Associations:

• H. pylori identified in tympanosclerotic ears (Saki et al.)
• Chlamydia pneumoniae identified as a possible etiology (Dinc et al.)

Genetic Factors:

• LP/J mouse and Enpp1^asj mutant mice — two animal models showing spontaneous tympanosclerosis, suggesting a genetic predisposition
• Mutations in the ENPP1 gene (encoding ectonucleotide pyrophosphatase/phosphodiesterase 1) implicated in aberrant calcification pathways

5. PATHOGENESIS — DUAL PATHWAY (Hussl & Lim, 1984)

PATHOGENESIS FLOWCHART (from Cummings — Fig. 140.19):

Connective tissue degeneration
        ↓
  Fibrolysis (enzymatic degradation by bacterial proteinases & collagenases)
        ↓
  "Hyalinization" (hypovascularity)
        ↓
  Change in local pH
        ↓
  Ca-phosphate precipitates
        ↓
  Dystrophic calcification
        ↓
  Calcified tympanosclerotic plaques (ossification)

Connective tissue degeneration
        ↓
  Fibrocyte degeneration
        ↓
  Extracellular matrix vesicles released (containing Ca²⁺ and PO₄³⁻ ions)
        ↓
  Supersaturation of ions
        ↓
  Ca-phosphate precipitates
        ↓
  Matrix vesicle calcification → Calcospherules
        ↓
  Calcified tympanosclerotic plaques (ossification)

6. PATHOLOGY

Gross Pathology:

• Chalky white, avascular, hard plaques
• Semicircular or horseshoe-shaped deposits within TM (pars tensa)
• In middle ear: deposits around promontory, malleus head, incus body, stapedial footplate
• Plaques attached to ossicles — "onion ring" layered pattern

Histopathology:

• Acellular hyalinisation of subepithelial connective tissue (lamina propria)
• Loss of normal collagen architecture — replaced by homogeneous eosinophilic matrix
• Dystrophic calcification — calcium hydroxyapatite deposits
• Calcospherules — concentric rings of calcified matrix vesicles
• Osteoneogenesis — new bone formation in severe cases (microscopically resembles woven/lamellar bone)
• Plaques limited to lamina propria of pars tensa in myringosclerosis
• Overlying epithelium is intact and normal
• No inflammatory cells in established plaques (acellular)

"Microscopically, collagen and fibrous tissue with hyaline degeneration is present within the lamina propria of the pars tensa and the middle ear mucosa. The deposition of hyaline occurs in layers similar to the rings of an onion and may reach a thickness of a few millimetres." — Cummings Otolaryngology

7. CLASSIFICATION

By Site (Tos Classification — Clinical Relevance):

By Extent (Surgical Classification):

• Localised — single plaque, TM only
• Diffuse — multiple plaques, entire TM
• Extensive — TM + ossicular chain + oval window

8. CLINICAL FEATURES

Symptoms:

• Hearing loss — conductive type; degree depends on ossicular involvement
• Hearing may be normal in pure myringosclerosis (TM plaques only)
• History of recurrent otitis media, grommet insertion, or ear surgery
• Tinnitus — occasionally
• No pain, no discharge (unless coexistent CSOM)

Signs — Otoscopic Findings:

• Chalky white semicircular/horseshoe-shaped plaques in pars tensa of TM
• Plaques may be bilateral
• TM may appear thickened, opaque, immobile
• In CSOM with tympanosclerosis: perforation + white plaques on remnant TM

Otoscopic Image — Tympanosclerosis (Myringosclerosis):

Multi-modal Diagnostic Image (CT + 3D + Otoscopy):

9. DIAGNOSIS

Clinical Diagnosis Flow:

History (recurrent AOM / OME / grommet / CSOM)
        ↓
Otoscopy → Chalky white TM plaques
        ↓
Pneumatic otoscopy → Reduced/absent TM mobility
        ↓
Tuning fork tests → CHL (BC normal, AC reduced)
Rinne negative, Weber lateralises to affected ear
        ↓
Pure Tone Audiogram → CHL (air-bone gap)
        ↓
Tympanometry → Type As (stiff) or Type B (if effusion)
        ↓
HRCT Temporal Bone → Confirm ossicular fixation, extent
        ↓
Intraoperative findings → Definitive

Investigations:

"Ossicular fixation from tympanosclerosis should be suspected as the cause of conductive hearing loss when a history of chronic infections is present or when tympanosclerosis is seen on the TM." — Cummings Otolaryngology

Differential Diagnosis:

10. MANAGEMENT

FLOWCHART — Management of Tympanosclerosis:

Tympanosclerosis
        ↓
      ASSESS
 ┌────────────┬────────────────────┐
 ↓            ↓                   ↓
TM only   Middle ear/           Diffuse +
(Myring-  Ossicular             Bilateral
osclerosis) involvement
 ↓            ↓                   ↓
Hearing   Conductive HL      Consider
normal?   (air-bone gap)     BAHA/HAs
 ↓
YES → Observe
 ↓
NO (large plaque
affecting TM) → Surgical removal
                during tympanoplasty
        ↓
        SURGERY
 ┌───────────────────────────────────┐
 ↓                                   ↓
TM + Ossicular             Stapes fixation
fixation (malleus,
incus)
 ↓                                   ↓
Stage I:                    Stapedectomy /
Myringoplasty +             Stapedotomy
Ossiculoplasty              (higher cochlear
(TORP/PORP)                 damage risk!)
 ↓
Stage II (if needed):
Ossicular reconstruction

A. Conservative Management:

• Observation — for myringosclerosis without hearing loss
• Hearing aids — for elderly, poor surgical candidates, bilateral disease
• BAHA (Bone-Anchored Hearing Aid) — particularly beneficial in tympanosclerosis with ossicular fixation, canal atresia; noted as specifically beneficial in Cummings (Ch. 136)

B. Surgical Management:

Principles (Tos, 1983 — Cummings Chapter 140):

"Whenever possible, an intact ossicular chain is preserved. When the disease is restricted to the TM remnant, smaller areas of myringosclerosis have no effect on hearing and can be left alone; however, tympanosclerosis that affects a large area should be removed and replaced with the graft."

Surgical Options:

Surgical Challenges:

• High risk of sensorineural hearing loss (SNHL) — due to extensive dissection required; cochlear damage from manipulation around oval window
• Smyth et al. — 79% excellent results with 2-stage ossicular reconstruction (stapedectomy + TORP)
• Gormley — only 7% had air-bone gap <21 dB on long-term follow-up after stapedectomy
• One-stage procedures — 21% cochlear loss in older series (Cummings)

Risk of Recurrence:

• Tympanosclerosis can recur after surgical removal — ongoing inflammation perpetuates the cycle
• Staging procedures help reduce operative trauma and cochlear risk

11. PROGNOSIS

12. RECENT ADVANCES

1. Molecular / Genetic Mechanisms:

• ENPP1 gene mutations (ectonucleotide pyrophosphatase/phosphodiesterase 1) — identified in Enpp1^asj mice model; ENPP1 regulates inorganic pyrophosphate (PPi) levels, a potent inhibitor of calcification; its dysfunction → excess calcium-phosphate deposition
• Free radical / oxidative stress hypothesis — reactive oxygen species (ROS) from chronic inflammation damage middle ear connective tissue, initiating the hyalinisation-calcification cascade
• Matrix metalloproteinase (MMP) dysregulation — MMPs (collagenases) play a role in aberrant collagen remodelling leading to plaque formation

2. Role of Biofilm:

• Bacterial biofilms (P. aeruginosa, H. influenzae, S. pneumoniae) persist in chronic otitis media; the biofilm microenvironment may potentiate tympanosclerotic changes by chronically stimulating inflammation
• Antibiotic-tolerant "persister cells" within biofilms maintain the chronic inflammatory stimulus

3. Imaging Advances:

• High-resolution CT (HRCT) of the temporal bone — now the gold standard preoperative investigation; delineates exact ossicular fixation, oval/round window involvement
• Cone-beam CT (CBCT) — lower radiation; comparable resolution; emerging role in pre-surgical planning
• 3D reconstruction imaging of ossicular chain — shows calcified deposits and their spatial relationship to critical structures

4. Surgical Advances:

• Endoscopic ear surgery (EES) — transcanal endoscopic approach allows superior visualisation of anterior epitympanum, oval window, and round window niche; improved access for removal of tympanosclerotic plaques with minimal trauma
• Laser-assisted surgery (CO₂, KTP, Er:YAG lasers) — precise removal of calcified plaques around stapes footplate, reducing mechanical trauma and SNHL risk
• Total ossicular replacement prostheses (TORP/PORP) made of hydroxyapatite or titanium — improved biocompatibility and long-term results
• Bone-anchored hearing aids (BAHA/Bonebridge) — increasingly preferred over high-risk ossicular surgery in pansclerosis

5. Free Radical Theory (Reactive Oxygen Species):

• Recent evidence implicates oxidative damage to middle ear mucosa — superoxide dismutase and catalase levels are reduced in tympanosclerotic ears
• N-acetylcysteine (NAC) and antioxidant therapy are experimental strategies to prevent recurrence post-surgery

6. Prevention:

• Proper management of AOM and OME reduces incidence
• Careful technique during ventilating tube insertion and myringotomy — reduces post-procedural tympanosclerosis
• Avoiding prolonged tube retention — long-dwell tubes associated with higher myringosclerosis rates

13. SUMMARY TABLE

REFERENCES (Standard Textbooks)

1. Cummings Otolaryngology: Head and Neck Surgery, 7th Edition — Flint PW et al. Chapter 140 (Chronic Otitis Media): Tympanosclerosis — Diagnosis, Pathogenesis, Management; Ossicular Fixation — pp. 2693–2695, 2734.
2. Scott-Brown's Otorhinolaryngology, Head and Neck Surgery — Gleeson M et al. Section on Tympanosclerosis and sequelae of chronic otitis media.
3. Stell and Maran's Head and Neck Surgery — Section on middle ear pathology and sequelae.
4. Diseases of Ear, Nose and Throat — P.L. Dhingra, 7th Edition — Chapter on Chronic Suppurative Otitis Media and Tympanosclerosis.
5. Hazarika's Textbook of Ear, Nose and Throat — Chapter on CSOM complications and tympanosclerosis.
6. K.J. Lee's Essential Otolaryngology — Tympanosclerosis in middle ear disease.
7. Hussl B, Lim DJ — Histopathology of tympanosclerosis. In: Lim DJ (ed). Recent Advances in Otitis Media with Effusion, Mosby, 1984.
8. Tos M — Surgical treatment of tympanosclerosis. ORL J Otorhinolaryngol Relat Spec, 1983.
9. Smyth GD et al. — Ossicular reconstruction in tympanosclerosis. Results of two-stage procedures.
10. Wielinga EWJ et al. — Eustachian tube obstruction and tympanosclerosis in rats. Acta Otolaryngol, 1993.

RGUHS Exam Tip: For a 50-mark answer, structure under: Definition → Aetiology → Pathogenesis (with dual-pathway flowchart) → Pathology → Classification → Clinical features → Investigations → Management (flowchart) → Recent advances → Prognosis. The pathogenesis flowchart (Hussl & Lim, from Cummings Fig. 140.19) and the management algorithm are high-yield marks. Emphasise the distinction between myringosclerosis (TM-only, no hearing loss) and true tympanosclerosis (middle ear + ossicular fixation → conductive HL), and the risk of SNHL with stapes surgery in tympanosclerosis.